The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection-Reference-Cited by-同舟云学术

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

Published:2023-01 Issue: Volume:209 Page:105453
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bluemling Gregory R.,Mao Shuli,Natchus Michael G.,Painter Wendy,Mulangu Sabue,Lockwood Mark,De La Rosa Abel,Brasel Trevor,Comer Jason E.,Freiberg Alexander N.,Kolykhalov Alexander A.,Painter George R.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Defense Threat Reduction Agency

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference33 articles.

1. Small molecule antiviral β-D-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance;Agostini;J. Virol.,2019

2. The need for a new strategy for Ebola vaccination;Bausch;Nat. Med.,2021

3. Ebola virus infection associated with transmission from survivors;Den Boon;Emerg. Infect. Dis.,2019

4. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever;Bray;J. Infect. Dis.,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus;Antiviral Research;2024-09

2. A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy;Bioorganic Chemistry;2024-06

3. New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses;Antiviral Research;2024-05

4. EIDD-1931 Treatment Tweaks CYP3A4 and CYP2C8 in Arthritic Rats to Expedite Drug Interaction: Implication in Oral Therapy of Molnupiravir;ACS Omega;2024-03-15

5. In vitro and in vivo efficacy of Molnupiravir against Zika virus infections;Virologica Sinica;2023-08